Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NJ Providers

Dr. Rini Palathingal, MD

Accepting New Patients

(52 Ratings)

Specializes in: Adult Oncology and Adult Hematology

Professional interests include: skin cancer, thrombophilia (clotting disorders), breast cancer, and more.

2 Journal Square Plaza 2nd Floor, Hematology/Oncology
Jersey City, NJ 07306

(201) 963-2213

Dr. Rini Palathingal, MD is an oncologist in Jersey City, NJ specializing in adult oncology and adult hematology. Dr. Rini Palathingal, MD is affiliated with Englewood Health and MEDICAL ASSOCIATES OF ENGLEWOOD PC.

Office Locations

Address:

2 Journal Square Plaza 2nd Floor, Hematology/Oncology
Jersey City, NJ 07306

Address:

435 57TH STREET
West New York, NJ 07093

Some issues Dr. Rini Palathingal, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

Thrombocytopenia (Low Platelet Count)

Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.

If a doctor suspects a patient has a thrombocytopenia, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytopenia can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Many people with thrombocytopenia can live healthy and fulfilling lives with proper treatment and precautions.

biological response modifier (BRM) therapy	167
blood draw	373
chemotherapy	167
doctor visit	863
hospital care	279
inpatient care	279
lab tests	809
minimally invasive procedures	338

**Gender**
Male	105
Female	227

**Ethnicity**
Non-Hispanic White	140
Black	50
Hispanic	118
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	103
From 75 to 84	120
85 and over	52
Less than 65	57

Hypertension	75
High Cholesterol	72
Stroke	8
Ischemic Heart Disease	57
Depression	19
Chronic Kidney Disease	38
Asthma	14
Osteoperosis	10
Atrial Fibrilation	11
Heart Failure	37
Chronic Obstructive Pulmonary Disease	30
Diabetes	55
Dementia	19
Cancer	45

biological response modifier (BRM) therapy	92
blood draw	378
chemotherapy	92
doctor visit	845
hospital care	164
inpatient care	164
lab tests	803
minimally invasive procedures	250

**Gender**
Male	97
Female	220

**Ethnicity**
Non-Hispanic White	125
Black	61
Hispanic	107
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	94
From 75 to 84	109
85 and over	55
Less than 65	59

Hypertension	75
High Cholesterol	64
Stroke	10
Ischemic Heart Disease	55
Depression	21
Chronic Kidney Disease	35
Asthma	16
Osteoperosis	16
Atrial Fibrilation	13
Heart Failure	32
Chronic Obstructive Pulmonary Disease	27
Diabetes	56
Dementia	21
Cancer	43

biological response modifier (BRM) therapy	122
blood draw	422
chemotherapy	122
doctor visit	781
hospital care	73
inpatient care	73
lab tests	842
minimally invasive procedures	311

**Gender**
Male	156
Female	372

**Ethnicity**
Non-Hispanic White	168
Black	96
Hispanic	218
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	178
From 75 to 84	192
85 and over	64
Less than 65	94

Hypertension	75
High Cholesterol	62
Stroke	7
Ischemic Heart Disease	49
Depression	19
Chronic Kidney Disease	35
Asthma	21
Osteoperosis	15
Atrial Fibrilation	9
Heart Failure	30
Chronic Obstructive Pulmonary Disease	24
Diabetes	55
Dementia	19
Cancer	45

biological response modifier (BRM) therapy	168
blood draw	463
chemotherapy	168
doctor visit	777
hospital care	44
inpatient care	44
lab tests	755
minimally invasive procedures	363

**Gender**
Male	78
Female	186

**Ethnicity**
Non-Hispanic White	81
Black	54
Hispanic	99
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	84
From 75 to 84	102
85 and over	39
Less than 65	39

Hypertension	75
High Cholesterol	65
Stroke	5
Ischemic Heart Disease	47
Depression	15
Chronic Kidney Disease	41
Asthma	25
Osteoperosis	13
Atrial Fibrilation	10
Heart Failure	27
Chronic Obstructive Pulmonary Disease	23
Diabetes	55
Dementia	16
Cancer	44

biological response modifier (BRM) therapy	158
blood draw	500
chemotherapy	158
doctor visit	698
hospital care	90
inpatient care	90
lab tests	726
minimally invasive procedures	262

**Gender**
Male	80
Female	191

**Ethnicity**
Non-Hispanic White	83
Black	47
Hispanic	108
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	101
From 75 to 84	105
85 and over	34
Less than 65	31

Hypertension	75
High Cholesterol	62
Stroke	7
Ischemic Heart Disease	46
Depression	20
Chronic Kidney Disease	46
Asthma	16
Osteoperosis	10
Atrial Fibrilation	11
Heart Failure	29
Chronic Obstructive Pulmonary Disease	24
Diabetes	54
Dementia	20
Cancer	43

biological response modifier (BRM) therapy	182
blood draw	413
chemotherapy	182
doctor visit	711
hospital care	52
inpatient care	52
lab tests	743
minimally invasive procedures	275

**Gender**
Male	84
Female	166

**Ethnicity**
Non-Hispanic White	75
Black	41
Hispanic	100
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	91
From 75 to 84	93
85 and over	35
Less than 65	31

Hypertension	75
High Cholesterol	70
Stroke	7
Ischemic Heart Disease	53
Depression	22
Chronic Kidney Disease	48
Asthma	13
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	26
Chronic Obstructive Pulmonary Disease	26
Diabetes	56
Dementia	18
Cancer	41

biological response modifier (BRM) therapy	86
blood draw	322
chemotherapy	86
doctor visit	662
hospital care	41
inpatient care	41
lab tests	491
minimally invasive procedures	187

**Gender**
Male	67
Female	175

**Ethnicity**
Non-Hispanic White	67
Black	42
Hispanic	103
Asian	19
Other	11
Native American	0

**Age**
From 65 to 74	86
From 75 to 84	77
85 and over	47
Less than 65	32

Hypertension	75
High Cholesterol	69
Stroke	9
Ischemic Heart Disease	46
Depression	28
Chronic Kidney Disease	49
Asthma	17
Osteoperosis	16
Atrial Fibrilation	10
Heart Failure	24
Chronic Obstructive Pulmonary Disease	21
Diabetes	59
Dementia	18
Cancer	42

blood draw	397
doctor visit	700
lab tests	389
minimally invasive procedures	97

**Gender**
Male	57
Female	140

**Ethnicity**
Non-Hispanic White	49
Black	29
Hispanic	90
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	72
From 75 to 84	73
85 and over	31
Less than 65	21

Hypertension	75
High Cholesterol	68
Stroke	7
Ischemic Heart Disease	47
Depression	24
Chronic Kidney Disease	50
Asthma	15
Osteoperosis	13
Atrial Fibrilation	9
Heart Failure	23
Chronic Obstructive Pulmonary Disease	17
Diabetes	55
Dementia	18
Cancer	40

blood draw	659
doctor visit	1539
lab tests	910
minimally invasive procedures	261

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Rini Palathingal, MD for Medicare patients.

The highest averages for the top procedures that Dr. Rini Palathingal, MD treated as an oncologist in Jersey City, NJ were lab tests, blood draw, minimally invasive procedures and chemotherapy.

biological response modifier (BRM) therapy	139
blood draw	436
chemotherapy	139
doctor visit	845
hospital care	106
inpatient care	106
lab tests	718
minimally invasive procedures	260

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Rini Palathingal, MD.

**Gender**
Male	72
Female	167

**Ethnicity**
Black / African American	42
Asian / Pacific Islander	1
Non-Hispanic White	78
Native American / Alaskan Native	0
Hispanic	94
Other	1

**Age**
75 to 84	87
85 and over	35
Less than 65	36
65 to 74	80

Average of Total of Conditions of Medicare patients treated by Dr. Rini Palathingal, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Rini Palathingal, MD treated were hypertension, high cholesterol, diabetes and ischemic heart disease.

Hypertension	60
High Cholesterol	53
Stroke	6
Ischemic Heart Disease	40
Depression	16
Chronic Kidney Disease	34
Asthma	13
Osteoporosis	10
Heart Failure	22
Chronic Obstructive Pulmonary Disease	19
Diabetes	44
Atrial Fibrillation	8
Cancer	34
Dementia	14

Education & Training

She completed residency at Metropolitan Hospital. She has a state license in New Jersey.

Residency: Metropolitan Hospital

Licensed In: New Jersey

Affiliations & Hospitals

Dr. Rini Palathingal, MD is associated with these hospitals and organizations:

Englewood Health

MEDICAL ASSOCIATES OF ENGLEWOOD PC

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Rini Palathingal, MD appears to accept the following insurance providers: Horizon Blue Cross Blue Shield, MagnaCare, EmblemHealth, WellCare, Fidelis Care, AmeriHealth, United Healthcare, Aetna, Oxford Health Plans, MHBP, Medicare, Medicaid, Empire BlueCross BlueShield, Humana, Railroad Medicare, Cigna, QualCare, GEHA, MVP Health Care, Private Healthcare Systems (PHCS), WellPoint, UnitedHealthcare, NALC, Clover Health, Nippon Life Insurance Co of America and APWU.

Insurance Accepted by Provider includes:

According to our sources, Dr. Rini Palathingal, MD accepts the following insurance providers:

Horizon Blue Cross Blue Shield

MagnaCare

EmblemHealth

WellCare

Fidelis Care

AmeriHealth

United Healthcare

Aetna

Oxford Health Plans

MHBP

Medicare

Medicaid

Empire BlueCross BlueShield

Humana

Railroad Medicare

Cigna

QualCare

GEHA

MVP Health Care

Private Healthcare Systems (PHCS)

WellPoint

UnitedHealthcare

NALC

Clover Health

Nippon Life Insurance Co of America

APWU

Show More

Ratings & Reviews

Dr. Rini Palathingal, MD has an exceptional overall rating with an average of 4.96 out of 5 stars based on 52 ratings. We collect ratings and reviews of Dr. Rini Palathingal, MD from all over the web to help you find the right in Jersey City, NJ.

4.96

Overall Rating

(52 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Rini Palathingal, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Novartis Pharmaceuticals Corporation	$1,268 TASIGNA $301	PROMACTA $206	FEMARA $199	KISQALI $184	SANDOSTATIN $86	Other $292
AstraZeneca Pharmaceuticals LP	$976 LYNPARZA $497	IMFINZI $255	TAGRISSO $132	Enhertu $37	CALQUENCE $12	Other $44
E.R. Squibb & Sons, L.L.C.	$805 OPDIVO $738	SPRYCEL $15	Reblozyl $12	$41
Astellas Pharma US Inc	$762 PADCEV $263	XTANDI $92	XOSPATA $29	$378
Incyte Corporation	$680 JAKAFI $534	MONJUVI $69	PEMAZYRE $15	$61
Other	$7,049 KEYTRUDA $409	Lenvima $254	IMBRUVICA $253	DARZALEX $233	Kadcyla $200	Other $5,699

**Types of Payments**
Food and Beverage	$10,049
Education	$1,491

Biography

Dr. Rini Palathingal's specialties are adult hematology and adult oncology. She practices in West New York, NJ and Jersey City, NJ. Clinical interests for Dr. Palathingal include leukemia, lung cancer, and anemia. According to Doctor.com, she is currently accepting new patients at her office in West New York, NJ.